Superdisintegrants Market to 2027 - Global Analysis and Forecasts By Type (Synthetic Superdisintegrants, Natural Superdisintegrants, Other Superdisintegrants); Formulation (Tablets, Capsules); Therapeutic Area (Neurological Diseases, Gastrointestinal Diseases, Oncology, Inflammatory Diseases, Infectious Diseases, Cardiovascular Diseases, Other Diseases), and Geography
- THE3479224
- 175 Pages
- January 2020
- Pharmaceuticals
The global Superdisintegrants market is projected to reach US$ 659.17 Mn in 2027 from US$ 369.56 Mn in 2019. The market is projected to grow with a CAGR of 7.6% from 2020-2027.
Driving factors include growing adoption of orally disintegrating drugs, increasing acceptability of generic drugs. However, the risk high cost associated with manufacturing of superdisintegrants is expected to hamper the market during the forecast period.
Cancer is one of the major cause of human death worldwide. In recent years, the cases of cancer have been increasing tremendously and the trend is anticipated to remain the same in the upcoming years. According to the World Health Organization in 2018, approximately 9.6 million deaths across the globe were due to cancer. Furthermore, the National Cancer Institute predicted that in 2018, approximately 1,735,350 new cancer cases would be diagnosed in the US.
Generic drugs refer to qualitative and quantitative compositions of active components whose bioequivalence has been demonstrated by suitable bioavailability studies. Cost efficiency is the prominent factor that is driving the acceptance and adoption of generic drugs across the world. For instance, according to the study published in Journal of Pharmaceutical Health Care and Sciences (2015), nearly 50.0–60.0% of drug use across the world was of generic drugs. Certain benefits such as superior treatment outcomes, cost benefits, and easy availability played a major part in higher consumption of generic medications. Such higher consumption of generic medications is directly correlated to increased manufacturing of drugs. Moreover, increasing popularity of orally disintegrating drugs is likely to drive the usage of superdisintegrants in generic drugs, which will ultimately drive the growth of the global superdisintegrants market during the forecast period.
The global Superdisintegrants market is segmented by type, formulation, therapeutic area. Based on type, the Superdisintegrants market is segmented into Synthetic Superdisintegrants, Natural Superdisintegrants and other superdisintegrants. In 2019, the Synthetic Superdisintegrants accounted for the largest market share in the global Superdisintegrants market by type. Synthetic disintegrants are more effective in lower concentrations as compared to starch; also they incorporate superior intragranularity Such merits of synthetic superdisintegrants are projected to drive the synthetic superdisintegrants segment in the global superdisintegrants market during the forecast period. Based on formulation, the Superdisintegrants market has been segmented into tablets and capsule. Furthermore based on therapeutic the market was segmented into gastrointestinal diseases, inflammatory diseases, neurological diseases, infectious diseases, cardiovascular diseases, oncology and other diseases.
Some of the essential primary and secondary sources included in the report are the National Institute of Cancer Prevention and Research (NICPR), Asociación Española Contra el Cáncer, British Generics Manufacturers Association , Canada Foundation of Innovation , European Federation of Pharmaceutical Industries and Associations , Japan Chronic Disease Self-Management Association and others.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Superdisintegrants Market – By Type
1.3.2 Global Superdisintegrants Market – By Formulation
1.3.3 Global Superdisintegrants Market – By Therapeutic Area
1.3.4 Global Superdisintegrants Market – By Geography
2. Superdisintegrants Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Superdisintegrants – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Superdisintegrants Market in North America: PEST Analysis
4.2.2 Superdisintegrants Market in Europe: PEST Analysis
4.2.3 Superdisintegrants Market in APAC: PEST Analysis
4.2.4 Superdisintegrants Market in MEA: PEST Analysis
4.2.5 Superdisintegrants Market – South and Central America PEST Analysis
4.3 Expert Opinion
5. Superdisintegrants Market – Key Dynamics
5.1 Drivers
5.1.1 Growing Adoption of Orally Disintegrating Drugs
5.1.2 Increasing Acceptability of Generic Drugs
5.2 Restraints
5.2.1 High Cost Associated with Manufacturing of Superdisintegrants
5.3 Opportunities
5.3.1 Emerging Pharmaceuticals Markets in Developing Countries
5.4 Trends
5.4.1 Growing Emphasis on Adoption of Novel Drug Delivery Systems
5.5 Impact Analysis
6. Superdisintegrants Market – Global Analysis
6.1 Global Superdisintegrants Market Revenue Forecast And Analysis
6.2 Global Superdisintegrants Market, By Geography - Forecast And Analysis
6.3 Positioning Of Key Players
6.3.1 DowDupont Inc.
6.3.2 Ashland
7. Superdisintegrants Market Analysis and Forecasts to 2027 – Type
7.1 Overview
7.2 Global Superdisintegrants, by Type, 2019 & 2027 (% Share)
7.3 Synthetic Superdisintegrants
7.3.1 Overview
7.3.2 Global Synthetic Superdisintegrants Market Revenue and Forecast to 2027 (US$ Mn)
7.3.2.1 Crospovidone Market
7.3.2.1.1 Overview
7.3.2.1.2 Global Crospovidone Market Revenue and Forecast to 2027 (US$ Mn)
7.3.2.2 Modified Starch Market
7.3.2.2.1 Overview
7.3.2.2.2 Global Modified Starch Market Revenue and Forecast to 2027 (US$ Mn)
7.3.2.3 Modified Cellulose Market
7.3.2.3.1 Overview
7.3.2.3.2 Global Modified Cellulose Market Revenue and Forecast to 2027 (US$ Mn)
7.3.2.4 Calcium Silicates Market
7.3.2.4.1 Overview
7.3.2.4.2 Global Calcium Starch Market Revenue and Forecast to 2027 (US$ Mn)
7.3.2.5 Ion Exchange Resins Market
7.3.2.5.1 Overview
7.3.2.5.2 Global Ion Exchange Resins Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Natural Superdisintegrants
7.4.1 Overview
7.4.2 Global Natural Superdisintegrants Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Other Superdisintegrants
7.5.1 Overview
7.5.2 Global Other Superdisintegrants Market Revenue and Forecast to 2027 (US$ Mn)
8. Superdisintegrants Market Analysis and Forecasts to 2027 – Formulation
8.1 Overview
8.2 Global Superdisintegrants Market, by Formulation, 2019 & 2027 (% Share)
8.3 Tablets
8.3.1 Overview
8.3.2 Global Tablets Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Capsules
8.4.1 Overview
8.4.2 Global Capsules Market Revenue and Forecast to 2027 (US$ Mn)
9. Superdisintegrants Market Analysis and Forecasts to 2027 – Therapeutic Area
9.1 Overview
9.2 Global Superdisintegrants Market, by Therapeutic Area, 2019 & 2027 (% Share)
9.3 Neurological Diseases
9.3.1 Overview
9.3.2 Global Neurological Diseases Market Revenue and Forecast to 2027 (US$ Mn)
9.4 Gastrointestinal Diseases
9.4.1 Overview
9.4.2 Global Gastrointestinal Diseases Market Revenue and Forecast to 2027 (US$ Mn)
9.5 Oncology
9.5.1 Overview
9.5.2 Global Oncology Market Revenue and Forecast to 2027 (US$ Mn)
9.6 Inflammatory Diseases
9.6.1 Overview
9.6.2 Global Inflammatory Diseases Market Revenue and Forecast to 2027 (US$ Mn)
9.7 Infectious Diseases
9.7.1 Overview
9.7.2 Global Infectious Diseases Market Revenue and Forecast to 2027 (US$ Mn)
9.8 Cardiovascular Diseases
9.8.1 Overview
9.8.2 Global Cardiovascular Diseases Market Revenue and Forecast to 2027 (US$ Mn)
9.9 Others
9.9.1 Overview
9.9.2 Global Others Market Revenue and Forecast to 2027 (US$ Mn)
10. Superdisintegrants Market – Geographic Analysis
10.1 North America Superdisintegrants Market, Revenue and Forecast to 2027
10.1.1 Overview
10.1.2 North America Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.3 North America Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.1.3.1 North America Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.1.4 North America Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
10.1.5 North America Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
10.1.6 North America Superdisintegrants Market, Revenue and Forecast to 2027, By Country (%)
10.1.7 US
10.1.7.1 US Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.7.2 US Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.1.7.2.1 US Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.1.7.3 US Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
10.1.7.4 US Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
10.1.8 Canada
10.1.8.1 Canada Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.8.2 Canada Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.1.8.2.1 Canada Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.1.8.3 Canada Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
10.1.8.4 Canada Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
10.1.9 Mexico
10.1.9.1 Mexico Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.9.2 Mexico Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.1.9.2.1 Mexico Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.1.9.3 Mexico Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
10.1.9.4 Mexico Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
10.2 Europe Superdisintegrants Market, Revenue and Forecast To 2027
10.2.1 Overview
10.2.2 Europe Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
10.2.3 Europe Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.2.3.1 Europe Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.2.4 Europe Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
10.2.5 Europe Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
10.2.6 Europe Superdisintegrants Market, Revenue and Forecast to 2027, By Country (%)
10.2.7 Germany
10.2.7.1 Germany Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
10.2.7.2 Germany Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.2.7.2.1 Germany Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.2.7.3 Germany Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
10.2.7.4 Germany Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
10.2.8 UK
10.2.8.1 UK Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
10.2.8.2 UK Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.2.8.2.1 UK Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.2.8.3 UK Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
10.2.8.4 UK Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
10.2.9 France
10.2.9.1 France Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
10.2.9.2 France Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.2.9.2.1 France Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.2.9.3 France Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
10.2.9.4 France Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
10.2.10 Spain
10.2.10.1 Spain Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
10.2.10.2 Spain Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.2.10.2.1 Spain Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.2.10.3 Spain Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
10.2.10.4 Spain Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
10.2.11 Italy
10.2.11.1 Italy Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
10.2.11.2 Italy Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.2.11.2.1 Italy Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.2.11.3 Italy Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
10.2.11.4 Italy Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
10.3 Asia Pacific Superdisintegrants Market, Revenue and Forecast To 2027
10.3.1 Overview
10.3.2 Asia Pacific Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
10.3.3 Asia Pacific Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.3.3.1 Asia Pacific Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.3.4 Asia Pacific Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
10.3.5 Asia Pacific Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
10.3.6 Asia Pacific Superdisintegrants Market, Revenue and Forecast to 2027, By Country (%)
10.3.7 China
10.3.7.1 China Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
10.3.7.2 China Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.3.7.2.1 China Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.3.7.3 China Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
10.3.7.4 China Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
10.3.8 Japan
10.3.8.1 Japan Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
10.3.8.2 Japan Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.3.8.2.1 Japan Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.3.8.3 Japan Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
10.3.8.4 Japan Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
10.3.9 India
10.3.9.1 India Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
10.3.9.2 India Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.3.9.2.1 India Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.3.9.3 India Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
10.3.9.4 India Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
10.3.10 South Korea
10.3.10.1 South Korea Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
10.3.10.2 South Korea Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.3.10.2.1 South Korea Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.3.10.3 South Korea Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
10.3.10.4 South Korea Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
10.3.11 Australia
10.3.11.1 Australia Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
10.3.11.2 Australia Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.3.11.2.1 Australia Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.3.11.3 Australia Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
10.3.11.4 Australia Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
10.4 Middle East & Africa Superdisintegrants Market, Revenue and Forecast to 2027
10.4.1 Overview
10.4.2 Middle East & Africa Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
10.4.3 Middle East & Africa Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.4.3.1 Middle East & Africa Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.4.4 Middle East & Africa Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
10.4.5 Middle East & Africa Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
10.4.6 Middle East & Africa Superdisintegrants Market, Revenue and Forecast to 2027, By Country (%)
10.4.7 Saudi Arabia
10.4.7.1 Saudi Arabia Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
10.4.7.2 Saudi Arabia Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.4.7.2.1 Saudi Arabia Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.4.7.3 Saudi Arabia Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
10.4.7.4 Saudi Arabia Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
10.4.8 UAE
10.4.8.1 UAE Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
10.4.8.2 UAE Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.4.8.2.1 UAE Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.4.8.3 UAE Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
10.4.8.4 UAE Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
10.4.9 South Africa
10.4.9.1 South Africa Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
10.4.9.2 South Africa Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.4.9.2.1 South Africa Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.4.9.3 South Africa Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
10.4.9.4 South Africa Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
10.5 South and Central America Superdisintegrants Market, Revenue and Forecast To 2027
10.5.1 Overview
10.5.2 South and Central America Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
10.5.3 South and Central Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.5.3.1 South and Central Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.5.4 South and Central Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
10.5.5 South and Central Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
10.5.6 South and Central America Superdisintegrants Market, Revenue and Forecast to 2027, By Country (%)
10.5.7 Brazil
10.5.7.1 Brazil Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
10.5.7.2 Brazil Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.5.7.2.1 Brazil Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.5.7.3 Brazil Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
10.5.7.4 Brazil Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
10.5.8 Argentina
10.5.8.1 Argentina Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
10.5.8.2 Argentina Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.5.8.2.1 Argentina Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
10.5.8.3 Argentina Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
10.5.8.4 Argentina Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
11. Superdisintegrants Market to 2027– Industry Landscape
11.1 Overview
12. Company Profiles
12.1 Ashland
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Asahi Kasei Corporation
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Avantor, Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 BASF SE
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Corel Pharma Chem
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Dow DuPont Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 DFE Pharma
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Financial Overview
12.7.4 Product Portfolio
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 JRS Pharma
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 MERCK KGAA
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Roquette Frères
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
